CGON
Price
$37.76
Change
-$1.65 (-4.19%)
Updated
Nov 13 closing price
Capitalization
2.88B
4 days until earnings call
Intraday BUY SELL Signals
EYPT
Price
$11.51
Change
-$0.48 (-4.00%)
Updated
Nov 13 closing price
Capitalization
952.88M
111 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

CGON vs EYPT

Header iconCGON vs EYPT Comparison
Open Charts CGON vs EYPTBanner chart's image
CG Oncology
Price$37.76
Change-$1.65 (-4.19%)
Volume$1.03M
Capitalization2.88B
EyePoint Pharmaceuticals
Price$11.51
Change-$0.48 (-4.00%)
Volume$1.14M
Capitalization952.88M
CGON vs EYPT Comparison Chart in %
CGON
Daily Signal:
Gain/Loss:
EYPT
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
CGON vs. EYPT commentary
Nov 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CGON is a Hold and EYPT is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 14, 2025
Stock price -- (CGON: $37.76 vs. EYPT: $11.51)
Brand notoriety: CGON and EYPT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CGON: 100% vs. EYPT: 86%
Market capitalization -- CGON: $2.88B vs. EYPT: $952.88M
CGON [@Biotechnology] is valued at $2.88B. EYPT’s [@Biotechnology] market capitalization is $952.88M. The market cap for tickers in the [@Biotechnology] industry ranges from $110.25B to $0. The average market capitalization across the [@Biotechnology] industry is $2.11B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CGON’s FA Score shows that 0 FA rating(s) are green whileEYPT’s FA Score has 1 green FA rating(s).

  • CGON’s FA Score: 0 green, 5 red.
  • EYPT’s FA Score: 1 green, 4 red.
According to our system of comparison, EYPT is a better buy in the long-term than CGON.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CGON’s TA Score shows that 3 TA indicator(s) are bullish while EYPT’s TA Score has 1 bullish TA indicator(s).

  • CGON’s TA Score: 3 bullish, 6 bearish.
  • EYPT’s TA Score: 1 bullish, 8 bearish.
According to our system of comparison, CGON is a better buy in the short-term than EYPT.

Price Growth

CGON (@Biotechnology) experienced а -4.86% price change this week, while EYPT (@Biotechnology) price change was +3.88% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.64%. For the same industry, the average monthly price growth was -3.56%, and the average quarterly price growth was +66.73%.

Reported Earning Dates

CGON is expected to report earnings on Nov 18, 2025.

EYPT is expected to report earnings on Mar 05, 2026.

Industries' Descriptions

@Biotechnology (+3.64% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CGON($2.88B) has a higher market cap than EYPT($953M). EYPT YTD gains are higher at: 54.497 vs. CGON (31.660). CGON has higher annual earnings (EBITDA): -157.09M vs. EYPT (-172.05M). CGON has more cash in the bank: 661M vs. EYPT (256M). CGON has less debt than EYPT: CGON (994K) vs EYPT (21.8M). EYPT has higher revenues than CGON: EYPT (51.9M) vs CGON (551K).
CGONEYPTCGON / EYPT
Capitalization2.88B953M303%
EBITDA-157.09M-172.05M91%
Gain YTD31.66054.49758%
P/E RatioN/AN/A-
Revenue551K51.9M1%
Total Cash661M256M258%
Total Debt994K21.8M5%
FUNDAMENTALS RATINGS
EYPT: Fundamental Ratings
EYPT
OUTLOOK RATING
1..100
7
VALUATION
overvalued / fair valued / undervalued
1..100
69
Overvalued
PROFIT vs RISK RATING
1..100
79
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
43
P/E GROWTH RATING
1..100
13
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CGONEYPT
RSI
ODDS (%)
Bearish Trend 3 days ago
90%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
78%
Bearish Trend 2 days ago
84%
Momentum
ODDS (%)
Bearish Trend 2 days ago
78%
Bearish Trend 2 days ago
88%
MACD
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
77%
Bullish Trend 2 days ago
84%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
78%
Bearish Trend 2 days ago
89%
Advances
ODDS (%)
Bullish Trend 19 days ago
77%
Bullish Trend 3 days ago
86%
Declines
ODDS (%)
Bearish Trend 10 days ago
80%
Bearish Trend 10 days ago
87%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
84%
Aroon
ODDS (%)
Bearish Trend 2 days ago
77%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
CGON
Daily Signal:
Gain/Loss:
EYPT
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RMBKX51.09-0.29
-0.56%
RMB Mendon Financial Services A
SHDCX8.99-0.10
-1.10%
American Beacon Shapiro SMID Cap Eq C
GCSLX24.32-0.30
-1.22%
Victory Pioneer Global Equity C
BAWAX54.31-0.99
-1.79%
Brown Advisory Sustainable Growth Adv
ACFCX76.16-2.16
-2.76%
American Century Focused Dynamic Gr R

CGON and

Correlation & Price change

A.I.dvisor indicates that over the last year, CGON has been loosely correlated with NUVL. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if CGON jumps, then NUVL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CGON
1D Price
Change %
CGON100%
-4.19%
NUVL - CGON
59%
Loosely correlated
-2.42%
SYRE - CGON
58%
Loosely correlated
-3.41%
ACLX - CGON
58%
Loosely correlated
-3.02%
IDYA - CGON
57%
Loosely correlated
-0.41%
KYMR - CGON
55%
Loosely correlated
+0.16%
More

EYPT and

Correlation & Price change

A.I.dvisor indicates that over the last year, EYPT has been loosely correlated with LYRA. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if EYPT jumps, then LYRA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EYPT
1D Price
Change %
EYPT100%
-4.00%
LYRA - EYPT
58%
Loosely correlated
-1.55%
OCUL - EYPT
55%
Loosely correlated
-2.61%
ATHE - EYPT
54%
Loosely correlated
-2.64%
ERAS - EYPT
52%
Loosely correlated
-4.15%
CGON - EYPT
48%
Loosely correlated
-4.19%
More